A fusion protein therapy may be an effective treatment option for cutaneous T-cell lymphomas, according to a multicenter ...

Researchers have determined how children's immune systems react to different kinds of cancer depending on their age. The study reveals significant differences between the immune response of children ...

Therapy will cost Rs 35 to 50 lakh. India sees around 1.20 lakh new blood cancer cases and over 70,000 deaths annually from ...

T-cell therapy, originally developed for haematological malignancies, has recently emerged as a promising therapy for ...

A group of immune proteins called the inflammasome can help prevent blood stem cells from becoming malignant by removing certain receptors from their surfaces and blocking cancer gene activity, ...

Regeneron Pharmaceuticals, Inc. REGN provided business and pipeline updates at the 43rd Annual J.P. Morgan Healthcare ...

Explore the journey of Georgie Swallow who was diagnosed with Stage 4 Hodgkin Lymphoma after ignoring symptoms Read ahead to ...

Lymphoid proliferations include benign (lymphoid hyperplasia and lymphadenitis) equivocal and malignant (lymphoma) conditions. AtLP have morphologic features equivocal between the benign and ...

1Mass General Cancer Center, Boston, Massachusetts. 2Harvard Medical School, Boston, Massachusetts. *Corresponding Author: Gregory M. Cote, Mass General Cancer Center ...

Despite recent therapeutic breakthroughs, cancer patients continue to face high recurrence and mortality rates due to treatment resistance. Cancer stem cells (CSCs), a subpopulation with self-renewal ...

A first-of-its-kind study shows how AI with noninvasive liquid blood plasma biopsy and Raman spectroscopy (RS) can detect and ...